Covered recipient · General Payments record
NEHEMIAH T TAN
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$5,268.50
- Reported across 339 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $645.58 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $290.92 | 16 |
| ABBVIE INC. | $115.96 | 6 |
| Acerta Pharma LLC | $41.44 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.92 | 1 |
| GlaxoSmithKline, LLC. | $34.44 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $33.68 | 2 |
| UCB, Inc. | $21.45 | 1 |
| Fresenius Kabi USA, LLC | $20.82 | 1 |
| Janssen Biotech, Inc. | $18.72 | 1 |
| Sandoz Inc. | $18.32 | 1 |
| Radius Health, Inc. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.75 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198788 | CMS |
| ABBVIE INC. | $28.13 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198790 | CMS |
| ABBVIE INC. | $15.64 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198792 | CMS |
| ABBVIE INC. | $25.41 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198794 | CMS |
| ABBVIE INC. | $15.69 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198796 | CMS |
| ABBVIE INC. | $14.34 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106198798 | CMS |
| Amgen Inc. | $9.13 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168800 | CMS |
| Amgen Inc. | $20.73 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168766 | CMS |
| Amgen Inc. | $19.47 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168806 | CMS |
| Amgen Inc. | $18.97 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168780 | CMS |
| Amgen Inc. | $16.79 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168786 | CMS |
| Amgen Inc. | $7.43 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168812 | CMS |
| Amgen Inc. | $14.59 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168772 | CMS |
| Amgen Inc. | $25.26 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168792 | CMS |
| Amgen Inc. | $12.74 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168818 | CMS |
| Amgen Inc. | $14.26 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168826 | CMS |
| Amgen Inc. | $28.76 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168840 | CMS |
| Amgen Inc. | $26.39 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116168832 | CMS |
| Amgen Inc. | $31.17 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117697454 | CMS |
| Amgen Inc. | $17.22 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117697458 | CMS |
| Amgen Inc. | $12.21 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117697456 | CMS |
| Amgen Inc. | $15.80 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117697460 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.84 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104423119 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.60 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105518049 | CMS |
| E.R. Squibb & Sons, L.L.C. | $35.92 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101575603 | CMS |
| Fresenius Kabi USA, LLC | $20.82 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146944307 | CMS |
| GlaxoSmithKline, LLC. | $15.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116000297 | CMS |
| GlaxoSmithKline, LLC. | $18.72 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116061174 | CMS |
| Janssen Biotech, Inc. | $18.72 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078584122 | CMS |
| Novartis Pharmaceuticals Corporation | $20.45 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087407252 | CMS |
| Novartis Pharmaceuticals Corporation | $13.23 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087407256 | CMS |
| Radius Health, Inc. | $13.91 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089979569 | CMS |
| Sandoz Inc. | $18.32 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089372803 | CMS |
| UCB, Inc. | $21.45 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143479491 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.